Clopidogrel is a generic prescription medication. It is FDA-approved to help prevent cardiovascular events such as heart attack and stroke in certain adults. Specifically, clopidogrel is approved to ...
The researchers found that the primary outcome was experienced by 17.6% of patients prescribed Plavix and 17.9% prescribed clopidogrel at 1 year (hazard ratio, 1.02; 95% confidence interval, 0.96 to 1 ...
For the second time in the past six months, a cardiology mainstay drug has lost patent protection and gone generic. Today the FDA announced that it had approved several generic versions of clopidogrel ...
Bridgewater/Princeton, NJ-The US FDA has approved a new 300-mg tablet of clopidogrel (Plavix, Sanofi-Aventis/Bristol-Myers Squibb) for use as a loading dose in acute ...
Sanofi-aventis and Bristol-Myers Squibb Company announced today that the US Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for a 300mg tablet of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results